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OPEN
ORIGINAL ARTICLE
Differential cell line susceptibility to the emerging
Zika virus: implications for disease pathogenesis,
non-vector-borne human transmission and animal
reservoirs
Jasper Fuk-Woo Chan1,2,3,4,*, Cyril Chik-Yan Yip2,*, Jessica Oi-Ling Tsang2, Kah-Meng Tee2, Jian-Piao Cai2,
Kenn Ka-Heng Chik2, Zheng Zhu2, Chris Chung-Sing Chan2, Garnet Kwan-Yue Choi2, Siddharth Sridhar2,
Anna Jinxia Zhang2, Gang Lu5, Kin Chiu6,7,8, Amy Cheuk-Yin Lo6,7, Sai-Wah Tsao9, Kin-Hang Kok2,3,
Dong-Yan Jin9, Kwok-Hung Chan2 and Kwok-Yung Yuen1,2,3,4,10
Zika virus (ZIKV) is unique among human-pathogenic ﬂaviviruses by its association with congenital anomalies and trans-placental
and sexual human-to-human transmission. Although the pathogenesis of ZIKV-associated neurological complications has been
reported in recent studies, key questions on the pathogenesis of the other clinical manifestations, non-vector-borne transmission
and potential animal reservoirs of ZIKV remain unanswered. We systematically characterized the differential cell line
susceptibility of 18 human and 15 nonhuman cell lines to two ZIKV isolates (human and primate) and dengue virus type 2
(DENV-2). Productive ZIKV replication (⩾2 log increase in viral load, ZIKV nonstructural protein-1 (NS1) protein expression and
cytopathic effects (CPE)) was found in the placental (JEG-3), neuronal (SF268), muscle (RD), retinal (ARPE19), pulmonary
(Hep-2 and HFL), colonic (Caco-2),and hepatic (Huh-7) cell lines. These ﬁndings helped to explain the trans-placental
transmission and other clinical manifestations of ZIKV. Notably, the prostatic (LNCaP), testicular (833KE) and renal (HEK) cell
lines showed increased ZIKV load and/or NS1 protein expression without inducing CPE, suggesting their potential roles in sexual
transmission with persistent viral replication at these anatomical sites. Comparatively, none of the placental and genital tract cell
lines allowed efﬁcient DENV-2 replication. Among the nonhuman cell lines, nonhuman primate (Vero and LLC-MK2), pig
(PK-15), rabbit (RK-13), hamster (BHK21) and chicken (DF-1) cell lines supported productive ZIKV replication. These animal
species may be important reservoirs and/or potential animal models for ZIKV. The ﬁndings in our study help to explain the viral
shedding pattern, transmission and pathogenesis of the rapidly disseminating ZIKV, and are useful for optimizing laboratory
diagnostics and studies on the pathogenesis and counter-measures of ZIKV.
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INTRODUCTION
Zika virus (ZIKV) is a mosquito-borne ﬂavivirus that has been largely
neglected for 60 years after its ﬁrst isolation from the serum of a febrile
sentinel rhesus macaque in the Zika Forest of Uganda in 1947.1 Since
2007, ZIKV has emerged to cause large epidemics of a dengue-like
illness in the Paciﬁc islands and Latin America, with imported cases
also reported in other continents.2,3 As of 14 July 2016, more than 60
countries/territories have reported continuing mosquito-borne trans-
mission of ZIKV.4 Although most patients infected with ZIKV have an
asymptomatic or a self-limiting acute febrile illness, some patients may
develop severe neurological complications, such as Guillain–Barré
syndrome, or fatal disseminated infections.2,5–7 Moreover, recent
clinico-epidemiological, laboratory and animal studies on pathogenesis
have established the association between ZIKV infection and con-
genital anomalies, such as microcephaly, central nervous system
malformations and ophthalmological abnormalities.8–13
ZIKV research has so far been mainly focused on the pathogenesis
of ZIKV-associated neurological complications. Questions on the
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pathogenesis of ZIKV’s other clinical manifestations, its unique ability
among ﬂaviviruses to be transmitted trans-placentally and sexually,
and its potential animal reservoirs remain mostly unanswered.
Although in vivo phenomena may not be completely reproducible in
the in vitro setting, cell line susceptibility studies are often useful for
providing critical data for these knowledge gaps in the early phases of
epidemics caused by emerging RNA viruses.14,15 In this study, we
correlated the differential cell line susceptibility, species tropism, viral
replication efﬁciency and antigen expression patterns with the clinical
and epidemiological characteristics of ZIKV, and compared them with
those of the closely related dengue virus type 2 (DENV-2). Our
ﬁndings provided novel implications on the disease pathogenesis,
transmission and potential animal reservoirs that could be applied to
optimize laboratory testing protocols and infection control strategies
for this global health emergency.
MATERIALS AND METHODS
Viral isolates
To investigate on the differential cell line susceptibility to epidemic
ZIKV and pre-epidemic ZIKV, we included a clinical isolate of ZIKV
(Puerto Rico strain PRVABC59) obtained from a patient in the recent
South American epidemic (ZIKV-PR; kindly provided by Brandy
Russell and Barbara Johnson, Centers for Disease Control and
Prevention, USA), and another pre-epidemic ZIKV strain isolated
from a nonhuman primate in Uganda in 1947 (976 Uganda strain)
(ZIKV-U; kindly provided by Tatjana Avšič Županc, University of
Ljubljana, Slovenia, the European Virus Archive). An archived clinical
isolate of DENV-2 was obtained from Department of Microbiology,
The University of Hong Kong, for comparison with ZIKV, as the two
viruses are closely related phylogenetically and have similar clinical
manifestations. The ZIKV and DENV-2 isolates were ampliﬁed by
three additional passages in Vero cells and C6/36 cells, respectively, to
make working stocks of the viruses.
Ethics statement
Institutional Review Board approval for use of the vial isolates was
obtained and all samples were anonymized. The cell lines used in this
study were obtained from sources listed in Table 1.
Viral culture
Viral culture was performed as we previously described with
modiﬁcations.14 Brieﬂy, 33 cell lines derived from different tissues
or organs and host species were each inoculated with one multiplicity
of infection of the ZIKV and DENV-2 isolates for 1 h (Table 1). Non-
attached virus was removed by washing the cells twice in phosphate-
buffered saline (Gibco, Thermo Fisher Scientiﬁc, Waltham, MA,
USA). The monolayer cells were maintained in minimum essential
medium, Dulbecco’s modiﬁed Eagle’s medium (DMEM), DMEM/F12
or RPMI medium, with 1% fetal calf serum, depending on the type of
cell line according to supplier’s instructions (Gibco). The suspension
cells were maintained in RPMI medium with 2% fetal calf serum
(Gibco). All infected cell lines were incubated at 37 °C for ﬁve days,
except C6/36 which was incubated at 28 °C. Cytopathic effects (CPE)
were examined at one, three and ﬁve days post-virus inoculation
(d.p.i) with inverted light microscopy.
RNA extraction and quantitative reverse-transcription PCR
Total nucleic acid (TNA) was extracted from culture supernatants of
the 33 cell lines infected by ZIKV or DENV-2 at 1, 3 and 5 d.p.i. using
EZ1 Virus Mini Kit v2.0 (Qiagen, Hilden, Germany) as we previously
described.16,17 Brieﬂy, 200 μL of supernatant were used for extraction
and the TNA was eluted in 60 μL of AVE buffer. Real-time one-step
quantitative reverse-transcription polymerase chain reaction (qRT-PCR)
was used for the detection of ZIKV and DENV-2 using QuantiNova
Probe RT-PCR Kit (Qiagen) in a LightCycler 96 Real-Time PCR
System (Roche Diagnostics, Basel, Switzerland). Five microliters of
puriﬁed TNA was ampliﬁed in a 20 μL-reaction containing 10 μL of
2× QuantiNova Probe RT-PCR Master Mix, 0.2 μL QN Probe RT-
mix, 0.8 μM forward primer, 0.8 μM reverse primer and 200 nM
probe. ZIKV detection was performed as previously described, with
slight modiﬁcations.18 Forward primer (5′-CGY TGC CCA ACA
CAA GG-3′), reverse primer (5′-CCA CYA AYG TTC TTTT GCA
BAC A-3′) and probe (5′-HEX-AGC CTA CCT TGA YAA GCA RTC
AGA CAC TC-IABkFQ-3′) targeting the ZIKV envelope gene were
used. For DENV-2 detection, forward primer (5′-GCA TAT
TGA CGC TGG GAR AGA C-3′), reverse primer (5′-CGY TCT
GTG CCT GGA WWG ATG-3′) and probe (5′-FAM-CAG
AGA TCC TGC TGT C-MGB-NFQ-3′) targeting the DENV-2
3’-untranslated region were used. Reactions were incubated at 45 °C
for 10 min, followed by 95 °C for 5 min, and then thermal cycled for
50 cycles (95 °C for 5 s, 55 °C for 30 s). A series of 10-fold dilutions
equivalent to 1× 102–1× 106 copies/reaction mixture were prepared to
generate calibration curves and run in parallel with the test samples.
Cloning and puriﬁcation of His6-tagged recombinant ZIKV and
DENV-2 NS1
Primers (5′-CAT ATG GAT GTG GGG TGC TCG GTG GAC T-3′
and 5′-CTC GAG TGC AGT CAC CAT TGA CCT TAC T-3′) were
used to amplify the gene encoding the ZIKV–nonstructural protein 1
(NS1) protein by RT-PCR. The sequence encoding a 352-amino-acid
fragment of ZIKV–NS1 protein was ampliﬁed and cloned into the
NdeI and XolI sites of expression vector pETH in frame and down-
stream of the series of six histidine residues. The recombinant ZIKV–
NS1 protein was expressed in Escherichia coli, denatured in 8 M urea,
and puriﬁed with Ni-nitrilotriacetic acid afﬁnity chromatography
(Qiagen) according to the manufacturer’s instructions. The solubilized
protein was refolded by slowly dialyzing with refolding buffers.
Expression of the recombinant ZIKV–NS1 protein was conﬁrmed
by western blot analysis using mouse anti-His monoclonal antibody
(Sigma-Aldrich, St Louis, MO, USA). Preparation of DENV-2-NS1
protein was performed as previously described.19
Preparation of speciﬁc antibodies against ZIKV- and DENV-2-NS1
proteins
This was performed as we previously described with modiﬁcations.14
Brieﬂy, 30 μg of puriﬁed recombinant ZIKV-NS1 protein was mixed
with an equal volume of complete Freund’s adjuvant (Sigma-Aldrich)
and injected subcutaneously into BALB/c mice. Incomplete Freund’s
adjuvant (Sigma-Aldrich) was used in subsequent injections at 14-day
intervals for three times. Serum samples were collected 14 days after
the fourth injection. Preparation of speciﬁc antibodies against
DENV-2-NS1 protein was performed as previously described.19
Antigen detection of infected cell lines by immunoﬂuorescence
This was performed as we previously described with modiﬁcations.14
Cell smears at 1, 3 and 5 d.p.i. were prepared and ﬁxed in chilled
acetone at − 20 °C for 10 min. The ﬁxed cells were incubated with
mouse antiserum against the ZIKV- or DENV-2-NS1 protein,
followed by FITC-rabbit anti-mouse IgG (Invitrogen, Carlsbad, CA,
USA). Cells were then examined under a ﬂuorescence microscope.
Three representative microscopic ﬁelds were chosen and 100 cells were
counted for characteristic cytoplasmic apple green ﬂuorescence.
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The mean percentage of positive cells was rounded up to the nearest
multiplicity of 10. Uninoculated cells were used as negative control.
Statistical analysis
The Student’s t-test was used to compare the mean viral load of the
different cell lines at 1, 3 and 5 d.p.i. with the mean baseline viral load
at 0 d.p.i. All calculations were based on log-transformed viral loads.
P-value of o0.01 was considered as statistically signiﬁcant.
Computation was performed using the Predictive Analytics Software
v18.0 for Windows.
RESULTS
Human cell lines
Eighteen human cell lines were tested (Table 1). ZIKV-PR and ZIKV-
U showed similar tropism as deﬁned by viral load, immunoﬂuorescent
antigen staining and CPE. A ⩾ 2 log increase in mean viral load
Table 1 Human and nonhuman cell lines used in the present study
Organism, anatomic site, cell line Abbreviations Source
Human
Placenta
Placental choriocarcinoma JEG-3 ATCC no. HTB-36
Genitourinary tract
Fetal kidney HEK In-house
Cervical adenocarcinoma HeLa ATCC no. CCL-2.2
Ovarian surface epithelium HOSE6-3 In-house
Metastatic prostatic adenocarcinoma LNCaP ATCC no. CRL-1740
Testicular germ cell tumor 833KE Sigma-Aldrich, St Louis, MO, USA
Neuromuscular cells
Anaplastic astrocytoma (non-epithelial) SF268 Research Center for Emerging Viral Infections, Chang Gung University, Taiwan
Rhabdomyosarcoma RD ATCC no. CCL-136
Retina
Retinal pigment epithelium ARPE19 ATCC no. CRL-2302
Respiratory tract
Laryngeal epidermoid carcinoma Hep-2 ATCC no. CCL-23
Lung adenocarcinoma Calu-3 ATCC no. HTB-55
Embryonic lung ﬁbroblasts HFL In-house
Gastrointestinal tract
Colorectal adenocarcinoma Caco-2 ATCC no. HTB-37
Liver
Hepatocellular carcinoma Huh-7 JCRB cell bank of Okayama University, Japan
Immune cells
Peripheral blood monocytes from acute monocytic leukemia THP-1 ATCC no. TIB-202
Monocytes from histiocytic lymphoma U937 ATCC no. CRL-1593.2
B lymphocytes from Burkitt’s lymphoma Raji ATCC no. CCL-86
T lymphocytes H9 ATCC no. HTB-176
Nonhuman
Mammals
African green monkey kidney Vero ATCC no. CCL-81
Rhesus monkey kidney LLC-MK2 ATCC no. CCL-7
Porcine kidney PK-15 ATCC no. CCL-33
Madin–Darby canine kidney MDCK ATCC no. CCL-34
Crandell Rees feline kidney CRFK ATCC no. CCL-94
Bat brain TP2 In-house
Mouse subcutaneous areolar and adipose tissue L929 ATCC no. CCL-1
Immortalized mouse microglia BV2 Cell Resource Center, Institute of Basic Medical Sciences, Chinese Academy of Medical
Sciences/Peking Union Medical College
Primary mouse embryonic ﬁbroblasts 3T3 ATCC no. CCL-92
Rat retinal precursor cells R28 Kerafast, Inc., Boston, MA, USA
Rat kidney RK3E ATCC no. CRL-1895
Rabbit kidney RK-13 ATCC no. CCL-37
Baby hamster kidney BHK21 ATCC no. CCL-10
Others
Chicken ﬁbroblasts DF-1 ATCC no. CRL-12203
Mosquito (Aedes albopictus) C6/36 ATCC no. CRL-1660
Abbreviation: American Tissue Culture Collection, ATCC.
Cell line susceptibility to Zika virus
JF-W Chan et al
3
Emerging Microbes & Infections
(Po0.01) within 5 d.p.i. was observed in 14/18 cell lines infected with
ZIKV-PR or ZIKV-U (Figures 1A and 1B). These included the
placental (JEG-3), genitourinary (HEK, HeLa, HOSE6-3, LNCaP
and 833KE), neuromuscular (SF268 and RD), retinal (ARPE19),
respiratory (Hep2, Calu-3 and HFL), intestinal (Caco-2) and hepatic
(Huh-7) cell lines. There was a slight increase in mean viral load of
about 0.5–1 lgcopies/mL in the monocyte (THP-1) and B lymphocyte
(Raji) cell lines (P40.01), but none of the immune cell lines achieved
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Figure 1 Differential human cell line susceptibility to (A) ZIKV-PR, (B) ZIKV-U and (C) DENV-2, as deﬁned by viral load, on days 1, 3 and 5 post-ZIKV
inoculation. All experiments were done in triplicate. The mean viral loads on days 1, 3 and 5 were compared with the mean baseline viral load on day 0 (1 h
post-ZIKV inoculation). All calculations were based on log-transformed viral loads. *P-value of o0.01.
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a ⩾ 2 log increase in mean viral load within 5 d.p.i. The highest mean
viral loads (⩾10 lgcopies/mL) were observed in the placental (JEG-3),
cervical (HeLa), neuronal (SF268), upper respiratory tract (Hep-2)
and intestinal (Caco-2) cell lines. Twelve of these 14 cell lines (JEG-3,
HEK, HeLa, LNCaP, SF268, RD, ARPE19, Hep-2, Calu-3, HFL, Caco-2
and Huh-7) showed obvious ZIKV-NS1 protein expression by IF in
addition to a high viral load (Table 2). The peak ZIKV-NS1 protein
expression in these cell lines occurred on 3–5 d.p.i. ZIKV-NS1 protein
Table 2 Differential cell line susceptibility to ZIKV-PR, ZIKV-U and DENV-2, as deﬁned by immunoﬂuorescent antigen staining on days 1, 3
and 5 after infection
Cell lines Immunoﬂuorescencea
ZIKV-PR ZIKV-U DENV-2
Day 1 Day 3 Day 5 Day 1 Day 3 Day 5 Day 1 Day 3 Day 5
Human
Placenta
JEG-3 (placenta) 50 60 80 60 70 80 N N N
Genitourinary tract
HEK (kidney) o1 1 5 10 20 20 1 20 20
HeLa (cervix) N o1 1 5 20 30 10 30 30
HOSE6-3 (endometrium) 1 1 1 1 5 5 N N N
LNCaP (prostate) 1 5 40 1 20 30 N N N
833KE (testis) N 1 1 N N 5 N N N
Neuromuscular cells
SF268 (neuron) 5 20 40 30 70 80 40 40 30
RD (muscle) 1 10 20 30 70 50 50 90 80
Retina
ARPE19 (retina) 5 60 50 20 60 60 10 30 30
Respiratory tract
Hep-2 (larynx) 1 5 10 10 30 30 10 20 50
Calu-3 (lung) 1 5 10 1 5 10 10 20 10
HFL (lung) 5 40 60 10 60 60 40 40 40
Gastrointestinal tract
Caco-2 (colon) 10 40 40 30 40 30 5 50 70
Liver
Huh-7 (liver) 20 60 100 50 80 100 50 80 80
Immune cells
THP-1 (monocyte) o1 o1 o1 N 1 1 N N N
U937 (monocyte) N N N N N N N N N
Raji (B lymphocyte) N N o1 o1 o1 5 N 1 40
H9 (T lymphocyte) N N N N o1 N N N o1
Nonhuman
Mammals
Vero (monkey) 40 50 70 70 80 90 50 90 100
LLC-MK2 (monkey) 1 20 30 20 90 90 40 80 70
PK-15 (pig) 10 40 40 30 70 70 20 60 70
MDCK (dog) 1 1 5 5 10 10 N N 5
CRFK (cat) N 1 1 N 5 5 N N 5
TP2 (bat) N N N N 5 10 20 30 30
L929 (mouse) N N N 5 5 1 1 1 1
BV2 (mouse) N N N N N N 5 5 N
3T3 (mouse) 1 5 10 5 20 10 o1 o1 o1
R28 (rat) N N N N N N o1 o1 o1
RK3E (rat) 5 5 5 10 10 10 N o1 o1
RK-13 (rabbit) 20 30 20 40 40 30 N N N
BHK21 (hamster) 10 70 80 30 50 50 50 50 50
Others
DF-1 (chicken) 1 30 70 40 70 70 N o1 o1
C6/36 (mosquito) 10 40 90 10 60 90 N 30 40
aN is deﬁned as negative. The numerals denote the mean percentage of positive cells from three representative microscopic ﬁelds, rounded up to the nearest multiplicity of 10.
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expression was most prominent (⩾50% of infected cells) in the
placental (JEG-3), neuronal (SF268), muscle (RD), retinal (APRE19),
lower respiratory tract (HFL) and hepatic (Huh-7) cell lines (Figure 2).
Although ovarian (HOSE6-3) and testicular (833KE) cells showed high
mean viral loads in qRT-PCR, ZIKV-NS1 protein expression was
consistently found in only ⩽ 5% of infected cells. CPE were observed
in 8 of these 14 cell lines, namely, JEG-3, SF268, RD, ARPE19, Hep-2,
HFL, Caco-2 and Huh-7 (Table 3). CPE were most prominent
(450% involvement) in the placental (JEG-3), neuronal (SF268),
muscle (RD), intestinal (Caco-2) and hepatic (Huh-7) cell lines
(Figure 3). The gradual onset of CPE in most of these cell lines at 3
d.p.i. correlated with the steady increase of viral load and ZIKV-NS1
protein expression at 3–5 d.p.i.
In contrast, DENV-2 showed a much narrower range of human
tissue tropism, with ⩾ 2 log increase in the mean viral load (Po0.01)
in only 9/18 cell lines (HEK, SF268, RD, ARPE19, Hep-2, Calu-3,
HFL, Caco-2 and Huh-7; Figure 1C). Notably, unlike ZIKV, the
DENV-2 load did not signiﬁcantly increase by ⩾ 2 lgcopies/mL in any
of the genital tract and placental cell lines, with only mildly increased
viral load (P40.01) and DENV-2-NS1 protein expression in the HeLa
cell line. Most of these nine cell lines with increased viral loads
demonstrated DENV-2-NS1 protein expression (Table 2) and CPE
(Table 3). The CPE were generally delayed in onset (5 d.p.i.) and
limited (⩽50%), except in the RD and Huh-7 cell lines.
Nonhuman cell lines
Fifteen nonhuman cell lines were tested (Table 1). ZIKV-PR and
ZIKV-U again showed similar tropism in these cell lines. A ⩾ 2 log
increase in mean viral load (Po0.01) was observed within 5 d.p.i. in
8/15 cell lines (Figures 4A and 4B). These included the nonhuman
primate (Vero and LLC-MK2), pig (PK-15), cat (CRFK), rabbit
(RK-13), hamster (BHK21), chicken (DF-1) and mosquito (C6/36)
cell lines. None of the mouse, rat and bat cell lines showed a ⩾ 2 log
increase in viral load within 5 d.p.i. The highest mean viral loads
(⩾10 lgcopies/mL) were observed in the nonhuman primate (Vero
and LLC-MK2), pig (PK-15), hamster (BHK21) and chicken (DF-1)
cell lines. All of these eight cell lines showed ZIKV-NS1 protein
expression by IF, usually starting on 3 d.p.i. and peaked on 5 d.p.i.
Figure 2 ZIKV nonstructural protein 1 expression by immunoﬂuorescence in cell lines representing the potential trans-placental, sexual and vector-borne
transmission routes, and/or genitourinary tissues with persistent viral replication of ZIKV. Expression of ZIKV nonstructural protein 1 as intense apple green
cytoplasmic ﬂuorescence in different cell lines stained by monospeciﬁc polyclonal serum from BALB/c mice immunized with His6-tagged recombinant ZIKV
nonstructural protein 1 at day 5 post-ZIKV inoculation (original magniﬁcation ×200). (A) Infected placental (JEG-3) cells; (B) uninfected JEG-3 control;
(C) infected prostatic (LNCaP) cells; (D) uninfected LNCaP control; (E) infected renal (HEK) cells; (F) uninfected HEK control; (G) infected mosquito (C6/36)
cells; (H) uninfected C6/36 control.
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(Table 2). ZIKV-NS1 protein expression was most prominent (⩾50%
of infected cells) in the nonhuman primate (Vero and LLC-MK2), pig
(PK-15), hamster (BHK21), chicken (DF-1) and mosquito (C6/36)
cell lines (Figure 2). Some of the mouse, rat and bat cell lines also
showed ZIKV-NS1 protein expression, but these expressions were
much less prominent than that in the other cell lines. CPE were
observed in six of these eight cell lines, including the nonhuman
primate (Vero and LLC-MK2), pig (PK-15), rabbit (RK-13), hamster
Table 3 Differential cell line susceptibility to ZIKV-PR, ZIKV-U and DENV-2, as deﬁned by cytopathic effect (CPE) on days 1, 3 and 5 after
infection
Cell lines CPE, gradea
ZIKV-PR ZIKV-U DENV-2
Day 1 Day 3 Day 5 Day 1 Day 3 Day 5 Day 1 Day 3 Day 5
Human
Placenta
JEG-3 (placenta) N 1+ 4+ 1+ 4+ 4+ N N N
Genitourinary tract
HEK (kidney) N N N N N N N N N
HeLa (cervix) N N N N 1+ 1+ N N N
HOSE6-3 (endometrium) N N N N N N N N N
LNCaP (prostate) N N N N N N N N N
833KE (testis) N N N N N N N N N
Neuromuscular cells
SF268 (neuron) N 2+ 2+ N 2+ 3+ N 1+ 2+
RD (muscle) N 1+ 2+ N 2+ 4+ N 4+ 4+
Retina
ARPE19 (retina) N 1+ 1+ N 1+ 2+ N 1+ 2+
Respiratory tract
Hep-2 (larynx) N N N N 1+ 1+ N N 1+
Calu-3 (lung) N N N N N N N N 1+
HFL (lung) N 1+ 1+ N 2+ 3+ N 2+ 2+
Gastrointestinal tract
Caco-2 (colon) N N 3+ N 3+ 4+ N N 1+
Liver
Huh-7 (liver) N 3+ 4+ 1+ 4+ 4+ N 2+ 4+
Immune cells
THP-1 (monocyte) N N N N N N N N N
U937 (monocyte) N N N N N N N N N
Raji (B lymphocyte) N N N N N N N 2+ 4+
H9 (T lymphocyte) N N N N N N N N 1+
Nonhuman
Mammals
Vero (monkey) N 3+ 4+ N 4+ 4+ N 1+ 1+
LLC-MK2 (monkey) N 1+ 2+ N 2+ 4+ N 4+ 4+
PK-15 (pig) N 2+ 2+ N 2+ 3+ N 1+ 2+
MDCK (dog) N N 1+ N 1+ 1+ N N 1+
CRFK (cat) N N N N N N N 1+ 1+
TP2 (bat) N N N N N N N 1+ 2+
L929 (mouse) N N N N N N N N N
BV2 (mouse) N N N N N N N N N
3T3 (mouse) N N N N N N N N N
R28 (rat) N N N N N N N 1+ 1+
RK3E (rat) N N N N N N N N N
RK-13 (rabbit) N N 1+ N 1+ 1+ N N N
BHK21 (hamster) N 1+ 2+ N 4+ 4+ 1+ 4+ 4+
Others
DF-1 (chicken) N N 1+ N 4+ 4+ N N N
C6/36 (mosquito) N N N N N N N N N
aN is deﬁned as negative, 1+ is deﬁned as 1–25% involvement, 2+ is deﬁned as 425% to 50% involvement, 3+ is deﬁned as 450% to 75% involvement and 4+ is deﬁned as 475%
involvement.
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(BHK21) and chicken (DF-1) cell lines, and were most prominent
(450% involvement) in the nonhuman primate, pig, hamster and
chicken cell lines (Table 3). CPE were not observed in the mosquito
(C6/36) cell line within 5 d.p.i.
A narrower range of nonhuman cell lines were susceptible to
infection by DENV-2 than ZIKV. A ⩾ 2 log increase in mean viral load
(Po0.01) within 5 d.p.i. was observed in only 6/15 cell lines, including
the nonhuman primate (Vero and LLC-MK2), pig (PK-15), bat (TP2),
hamster (BHK21) and mosquito (C6/36) cell lines (Figure 4C). All of
these six cell lines demonstrated DENV-2-NS1 protein expression by
IF (Table 2). CPE were observed in ﬁve of these six cell lines (all
except C6/36), but was usually not prominent (⩽50%) except in the
LLC-MK2 and BHK21 cell lines (Table 3).
DISCUSSION
Although ZIKV infection has been described as a dengue-like illness in
the past, recent evidence suggests that ZIKV is unique among known
human-pathogenic ﬂaviviruses. ZIKV is the ﬁrst ﬂavivirus known to
be associated with congenital malformations, and sexual and vertical
transmissions in human.1,8,9,20–22 The pathogenesis of these unusual
clinical manifestations and transmission routes is incompletely
understood. Moreover, a comprehensive surveillance for potential
animal reservoirs of ZIKV, which are likely important in facilitat-
ing the spread of the virus after 60 years of quiescence, has not
been reported. A virus’ ability to grow in cells of different host
species might provide insight into its ability to cross interspecies
barriers. We therefore conducted this systematic study to char-
acterize the tropism of the emerging ZIKV in a broad range of
human and nonhuman cell lines derived from different tissues or
organs and host species. The ﬁndings in our study may have
important clinical and epidemiological implications for this rapidly
expanding viral epidemic.
Productive ZIKV replication as deﬁned by ⩾ 2 log increase in mean
viral load, ZIKV-NS1 protein expression by IF, and presence of CPE
was observed within 5 d.p.i. in 8/18 human cell lines, which
represented cells of placental, neuronal, muscle, retinal, pulmonary,
intestinal and hepatic origin. This broad tissue tropism is likely related
to the wide distribution of the candidate receptors of ZIKV, including
AXL, TYRO3 and DC-SIGN, in different organs.23 The placental
(JEG-3) and neuronal (SF268) cell line tropism corroborated with
the congenital and neurological manifestations of ZIKV infection.
These manifestations include congenital microcephaly and other
Figure 3 Cytopathic effects in cell lines representing the major organs with clinical manifestations in ZIKV infection. Cytopathic effects consisting of cell
rounding, detachment and degeneration were observed in different cell lines at day 5 post-ZIKV inoculation under inverted microscopy (original magniﬁcation
×100). (A) Infected neuronal (SF268) cells; (B) uninfected SF268 control; (C) infected retinal (ARPE19) cells; (D) uninfected ARPE19 control; (E) infected
muscle (RD) cells; (F) uninfected RD3 control; (G) infected hepatic (Huh-7) cells; (H) uninfected Huh-7 control.
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central nervous system malformations in infected fetuses, and
meningoencephalitis, myelitis, and post-infectious Guillain–Barré
syndrome in adults.1,5,8,24 ZIKV RNA, full-length viral genome and/
or viral particles could be detected in the brain tissue of fetuses with
congenital microcephaly.8,25 Microscopically, ﬂavivirus-like virions
were observed together with extensive inﬂammation, astrocyte and
microglial activation, and injury in the cortex and the lateral
corticospinal tracts in the fetal brain tissue.8,25 Moreover, ZIKV could
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Figure 4 Differential nonhuman cell line susceptibility to (A) ZIKV-PR, (B) ZIKV-U and (C) DENV-2, as deﬁned by viral load, on days 1, 3 and 5 post-ZIKV
inoculation. All experiments were done in triplicate. The mean viral loads on days 1, 3 and 5 were compared with the mean baseline viral load on day 0 (1 h
post-ZIKV inoculation). All calculations were based on log-transformed viral loads. *P-value of o0.01.
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impair growth and deplete neural progenitor cells in human neuro-
spheres and cerebral organoids.26,27
Consistent with ZIKV’s tropism for the human rhabdomyosarcoma
(RD) cell line, myalgia and arthralgia with periarticular edema are
common features in symptomatic ZIKV infection. Fetuses with
congenital ZIKV infection may develop arthrogryposis.28 Myositis
and myocarditis were observed in suckling mice inoculated with ZIKV
intracerebrally, and viral RNA could be detected in the muscle and
heart of type I interferon receptor-deﬁcient mice infected with
ZIKV.29,30
Viral tropism for the retinal (ARPE19) cell line corroborates with
the ophthalmological complications of congenital ZIKV infection,
including chorioretinal atrophy and pigmentary maculopathy.10,13
Abdominal symptoms including diarrhea, vomiting, abdominal pain
and jaundice with hepatic dysfunction have been reported in patients
with ZIKV infection, and are in agreement with the susceptibility of
the intestinal (Caco-2) and hepatic (Huh-7) cell lines to ZIKV.1,6,7,31
Respiratory distress may occur in severe ZIKV infection, and this
correlates with ZIKV’s tropism for respiratory (Hep-2, Calu-3 and
HFL) cell lines.6,7 Similarly, the clinical features of DENV infection,
including encephalopathy/encephalitis (SF268), myalgia and rhabdo-
myolysis (RD), retinitis (ARPE19), respiratory symptoms (Hep-2 and
HFL), diarrhea (Caco-2) and hepatic dysfunction (Huh-7), also
correlated with the cell line susceptibility to DENV-2 in our
study.32,33
Although neurological manifestations may also be seen in infections
caused by other ﬂaviviruses, such as DENV, yellow fever virus, West
Nile virus (WNV) and Japanese encephalitis virus (JEV), none of these
ﬂaviviruses have been associated with congenital microcephaly and
central nervous system malformations. These unique clinical features
of ZIKV infection require the virus to be able to infect neural
progenitor cells of the fetus in utero during early gestation. A striking
difference between the cell line susceptibilities of ZIKV and DENV-2
observed in our study was ZIKV’s ability to productively replicate in
placental cells (JEG-3). JEG-3 cells infected with ZIKV produced high
viral loads (~10 lgcopies/mL), abundant ZIKV-NS1 protein expression
and prominent CPE. This ﬁnding helped to explain the unique ability
of ZIKV to infect the fetus via the placenta and cause congenital
anomalies, particularly when the infection occurred during the ﬁrst
trimester.34 Although a previous study suggested that type III
interferons produced by human placental trophoblasts could confer
protection against ZIKV infection, it is notable that the study utilized
primary human trophoblasts of full-term instead of early gestation
placenta.35 Indeed, our in vitro ﬁnding concurred with the recent
reports of detectable viral particles and RNA in trophoblasts of the
maternal and fetal placenta of ZIKV-infected type I interferon
signaling-deﬁcient mice and permissibility of placental macrophages
and cytotrophoblasts to productive ZIKV infection.12,36
Besides trans-placental transmission, our ﬁndings also provided
insights to explain the pathogenesis of other non-vector-borne human
transmission routes of ZIKV. Probable sexual transmission of
ZIKV has been reported.20–22 ZIKV-infected male patients might
develop hematospermia and perineal pain compatible with prostatitis,
and might have detectable viral RNA and/or infectious viral particles
in their semen.20–22 In contrast to DENV-2, which did not efﬁciently
replicate in any of the genital tract cell lines, the mean ZIKV load
signiﬁcantly increased in the prostatic (LNCaP) and testicular (833KE)
cell lines without inducing CPE. This suggested that the prostate and
testes might be important sites of ZIKV replication that led to
prolonged virus shedding in the semen of infected men.20,21,37
Interestingly, abundant ZIKV-NS1 protein expression was detected
in ZIKV-infected LNCaP cells, but not 833KE cells. This ﬁnding might
imply that ZIKV could replicate more efﬁciently in the prostate than
the testes. Recent studies only reported high viral loads in the testes of
ZIKV-infected mice deﬁcient in interferon signaling and/or receptor,
but did not report the viral loads in their prostates.30,38 Further studies
should be conducted to investigate the prostate’s role as a replication
site of ZIKV. The female genital tract cell lines, including HeLa and
HOSE6-3, were also susceptible to ZIKV, supporting the hypothesis
that non-immune women might acquire the infection through sexual
intercourse with their ZIKV-infected male partners.
We showed that the renal (HEK) and respiratory tract (Hep-2,
Calu-3, HFL) cell lines were also susceptible to ZIKV. This helped to
explain the high viral loads in the urine and nasopharyngeal swabs of
ZIKV-infected patients.39–41 The ﬁnding of high viral load and
abundant ZIKV-NS1 protein expression without inducing CPE in
HEK cells is particularly interesting, as it suggests that the kidney
might be another site of persistent ZIKV replication. Similarly,
DENV-2 infection also caused increased mean viral load and
DENV-2-NS1 protein expression without inducing CPE in HEK cells,
and viral RNA might be detected in urine of dengue patients.42 An
important implication of this ﬁnding is that kidney transplant donors
in ZIKV-affected regions should be tested for the infection before
organ donation, as virus shedding in urine might be prolonged.39–41
The intestinal (Caco-2) cell line was also highly susceptible to ZIKV,
which corroborated with the high viral load detected in the intestines
of ZIKV-infected mice.43 Serial testing of fecal samples of ZIKV-
infected patients should be performed to determine whether feces
represent another possible transmission route of ZIKV. It would also
be interesting to investigate ZIKV’s ability to productively replicate in
salivary gland cells, as high viral load could also be detected in the
saliva of ZIKV-infected patients.41,44
The differential cell line susceptibility of our nonhuman cell lines to
ZIKV may provide insights into the virus’ potential animal reservoirs
and alternative animal models. The ﬁnding of high viral loads and
abundant ZIKV-NS1 protein expression without induction of CPE
within 5 d.p.i. in the Aedes albopictus (C6/36) cell line was quite
expected, and corroborated with the high non-fatal infection, dis-
semination and transmission rates of ZIKV in infected A. albopictus.45
A ⩾ 2 log increase in mean viral load with ZIKV-NS1 protein
expression and CPE were observed in the nonhuman primate (Vero
and LLC-MK2), pig (PK-15), rabbit (RK-13), hamster (BHK21) and
chicken (DF-1) cell lines. It is well known that the transmission of
ﬂaviviruses may involve sylvatic cycles between the mosquito vectors
and susceptible wild animals, and urban cycles between the vectors
and domestic animals.46,47 Nonhuman primates are known wild
animal reservoirs of ZIKV and DENV.1,46 Our ﬁndings of efﬁcient
ZIKV replication in pig, rabbit, hamster and chicken cell lines suggest
that these mammalian or avian species might have a role in the
transmission of ZIKV. Similar to domestic pigs and wild birds for JEV,
and domestic and wild birds for WNV, these species may serve as the
animal reservoirs or amplifying hosts of ZIKV.46 Moreover, vector-free
JEV transmission due to persistence of virus in tonsils and virus
shedding in oronasal secretions of pigs has recently been reported.48
Alternatively, these animal species may be susceptible hosts with less
importance in the transmission cycle, which is analogous to horses for
JEV and many vertebrate species for WNV.46 Systematic sampling of
domestic animals in ZIKV-affected regions would help to conﬁrm
these ﬁndings. Pigs, rabbits and hamsters should be evaluated as
animal models for ZIKV infection, as interferon signaling- or
receptor-deﬁcient mice are not routinely available in most
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laboratories. Pig and/or hamster models have been previously reported
for DENV and WNV infection.49,50
Our ﬁndings are useful for optimizing laboratory diagnostics and
studies on the pathogenesis and counter-measures of ZIKV. Some of
the laboratories in resource-limited areas affected by ZIKV may not
have the capability to routinely perform molecular diagnostic tests. In
addition to the few cell lines previously reported, our study has
identiﬁed a broad range of cell lines that are suitable for growing ZIKV
as an alternative diagnostic tool in clinical virology laboratories.51–54
These cell lines may also be used in pathogenesis studies conducted by
laboratories without the technical expertise to handle brain organoids,
and to evaluate antiviral treatment and vaccines in vitro prior to
animal experiments.
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